VTEU: Phase I Influenza Vaccine Clinical Trial
$560,492N01FY2016AINIH
Vanderbilt University, Nashville TN
Investigators
Abstract
This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.
View original record on NIH RePORTER →